The HCM City Export Processing and Industrial Zones Authority (HEPZA)has worked with local drug producers to launch a programme to take careof workers' health with the use of locally made medicine.
The programme aims to provide better healthcare at lower costs fornearly 300,000 workers in the city's industrial parks (IPs) and exportprocessing zones (EPZs).
Most workers at IPs and EPZs are migrants who work long hours in potentially harmful working environments.
Their accommodations often do not meet standards, making it easy forthem to be infected with disease, according to the city Department ofHealth.
Most enterprises in IPs and EPZs have healthcare rooms,but attention has not been paid to worker's health as enterprises haveinvested little in healthcare rooms or facilities, according to a HEPZAofficial.
Tran Dinh Khoa, sales director of Sai GonPharmaceutical Company Limited (Sapharco), said his company had suppliedmedicine for 27 healthcare rooms and clinics in IPs and EPZs.
However, the supply of medicine for these facilities was insufficient, Khoa said.
"Responding to the programme, Sapharco will take the initiative insupplying medicines with the best quality and stable prices forhealthcare rooms and clinics in IPs and EPZs," he said.
Other local and joint-stock pharmaceutical companies, includingSavipharm, Fresenius Kabi Bidiphar and Ampharco, have also participatedin the programme.
The programme is also a responseto the Ministry of Health's campaign to encourage people to givepriority to made-in-Vietnam medicines which have good quality atreasonable prices.
Pham Khanh Phong Lan, deputydirector of the city Department of Health, said to encourage people touse made-in-Vietnam drugs, her department would organise seminars andvisits to local pharmaceutical companies and doctors.
The city has 20 pharmaceutical companies and they all meet high standards.
Lan has also asked the ministry to encourage the use of Vietnamesedrugs, including investing more in the production of specialised drugs,restricting imports that can be produced locally, and enhancing thequality of locally produced medicines./.
The programme aims to provide better healthcare at lower costs fornearly 300,000 workers in the city's industrial parks (IPs) and exportprocessing zones (EPZs).
Most workers at IPs and EPZs are migrants who work long hours in potentially harmful working environments.
Their accommodations often do not meet standards, making it easy forthem to be infected with disease, according to the city Department ofHealth.
Most enterprises in IPs and EPZs have healthcare rooms,but attention has not been paid to worker's health as enterprises haveinvested little in healthcare rooms or facilities, according to a HEPZAofficial.
Tran Dinh Khoa, sales director of Sai GonPharmaceutical Company Limited (Sapharco), said his company had suppliedmedicine for 27 healthcare rooms and clinics in IPs and EPZs.
However, the supply of medicine for these facilities was insufficient, Khoa said.
"Responding to the programme, Sapharco will take the initiative insupplying medicines with the best quality and stable prices forhealthcare rooms and clinics in IPs and EPZs," he said.
Other local and joint-stock pharmaceutical companies, includingSavipharm, Fresenius Kabi Bidiphar and Ampharco, have also participatedin the programme.
The programme is also a responseto the Ministry of Health's campaign to encourage people to givepriority to made-in-Vietnam medicines which have good quality atreasonable prices.
Pham Khanh Phong Lan, deputydirector of the city Department of Health, said to encourage people touse made-in-Vietnam drugs, her department would organise seminars andvisits to local pharmaceutical companies and doctors.
The city has 20 pharmaceutical companies and they all meet high standards.
Lan has also asked the ministry to encourage the use of Vietnamesedrugs, including investing more in the production of specialised drugs,restricting imports that can be produced locally, and enhancing thequality of locally produced medicines./.
